Hyundai Bioscience Archives

Hyundai Bioscience, U.S. NIH to Co-develop Broad-spectrum Antiviral Drug

SEOUL, Aug. 13 (Korea Bizwire) — Hyundai Bioscience Co. said Sunday it will develop a broad-spectrum antiviral drug with the U.S. National Institutes of Health (NIH), a federal agency for conducting and supporting medical research. Hyundai Bioscience USA, a wholly owned subsidiary of Hyundai Bioscience Co., signed a Non-Clinical Evaluation Agreement (NCEA) with the National [...]

Hyundai Bioscience COVID-19 Treatment Candidate Shows Efficacy with Dexamethasone

SEOUL, Dec. 7 (Korea Bizwire) — South Korean biotechnology firm Hyundai Bioscience Co. said Tuesday that the combination of its oral antiviral candidate and dexamethasone showed high efficacy in treating COVID-19 during animal testings. The company is currently re-purposing niclosamide-based CP-COV03 as a potential treatment for the COVID-19 virus. The investigative drug’s indication also includes [...]